Hoover EC - Search Results

1

Antibody/siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem-Like Behavior in Triple-Negative Breast Cancer Cells.

Hoover EC, Day ES. Hoover EC, et al. J Biomed Mater Res A. 2025 Jan;113(1):e37867. doi: 10.1002/jbm.a.37867. J Biomed Mater Res A. 2025. PMID: 39760151

2

Antibody Nanocarriers for Cancer Management.

Dang MN, Hoover EC, Scully MA, Sterin EH, Day ES. Dang MN, et al. Among authors: hoover ec. Curr Opin Biomed Eng. 2021 Sep;19:100295. doi: 10.1016/j.cobme.2021.100295. Epub 2021 May 26. Curr Opin Biomed Eng. 2021. PMID: 34423177 Free PMC article.

3

Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast Cancer.

Scully MA, Wilkins DE, Dang MN, Hoover EC, Aboeleneen SB, Day ES. Scully MA, et al. Among authors: hoover ec. Mol Pharm. 2023 Aug 7;20(8):3895-3913. doi: 10.1021/acs.molpharmaceut.3c00009. Epub 2023 Jul 17. Mol Pharm. 2023. PMID: 37459272 Free PMC article.

4

FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer.

Hoover EC, Ruggiero OM, Swingler RN, Day ES. Hoover EC, et al. ACS Omega. 2024 Mar 16;9(12):14323-14335. doi: 10.1021/acsomega.3c10275. eCollection 2024 Mar 26. ACS Omega. 2024. PMID: 38559981 Free PMC article.

5

Antibody and siRNA Nanocarriers to Suppress Wnt Signaling, Tumor Growth, and Lung Metastasis in Triple-Negative Breast Cancer.

Dang MN, Suri S, Li K, Casas CG, Stigliano G, Riley RS, Scully MA, Hoover EC, Aboeleneen SB, Kramarenko GC, Day ES. Dang MN, et al. Among authors: hoover ec. Adv Ther (Weinh). 2024 Jun;7(6):2300426. doi: 10.1002/adtp.202300426. Epub 2024 Apr 26. Adv Ther (Weinh). 2024. PMID: 39006318

6

Conjugation of Antibodies and siRNA Duplexes to Polymer Nanoparticles via Maleimide-Thiol Chemistry.

Hoover EC, Roy Chowdhury C, Ruggiero OM, Day ES. Hoover EC, et al. ACS Omega. 2024 Nov 18;9(48):47637-47646. doi: 10.1021/acsomega.4c07025. eCollection 2024 Dec 3. ACS Omega. 2024. PMID: 39651074 Free PMC article.

7

Target an arbitrary probability of response using weighted staircase procedures.

Hoover EC. Hoover EC. J Acoust Soc Am. 2025 Jan 1;157(1):191-202. doi: 10.1121/10.0034861. J Acoust Soc Am. 2025. PMID: 39807878

8

Alignment of Audiologists' Values With Best-Practice Standards: Insights From a National Survey.

Menon KN, Hoover EC. Menon KN, et al. Among authors: hoover ec. Am J Audiol. 2024 Dec 2;33(4):1291-1305. doi: 10.1044/2024_AJA-24-00102. Epub 2024 Nov 13. Am J Audiol. 2024. PMID: 39535962

9

Over-the-Counter Hearing Aids Challenge the Core Values of Traditional Audiology.

Menon KN, Hoon-Starr M, Shilton K, Hoover EC. Menon KN, et al. Among authors: hoover ec. J Speech Lang Hear Res. 2024 Feb 12;67(2):657-667. doi: 10.1044/2023_JSLHR-23-00306. Epub 2024 Feb 8. J Speech Lang Hear Res. 2024. PMID: 38329402 Free PMC article.

10

Validation of the adaptive scan method in the quest for time-efficient methods of testing auditory processes.

Lelo de Larrea-Mancera ES, Stavropoulos T, Carrillo AA, Menon KN, Hoover EC, Eddins DA, Gallun FJ, Seitz AR. Lelo de Larrea-Mancera ES, et al. Among authors: hoover ec. Atten Percept Psychophys. 2023 Nov;85(8):2797-2810. doi: 10.3758/s13414-023-02743-z. Epub 2023 Jun 22. Atten Percept Psychophys. 2023. PMID: 37349625 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters